enGene Therapeutics Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company in Canada. The company develops genetic medicines to help patients suffering from bladder cancer. Its lead product candidate i...
Q1 2026
Mar 9, 2026
FY 2025
Dec 22, 2025
Q4 2025
Q3 2025
Sep 11, 2025
Q2 2025
Jun 12, 2025